Buy Day today: Good (67) Broad market participation · no major macro event

Travere Therapeutics Inc (TVTX)

Healthcare Biotechnology

55.00 $

-1.6% vs. previous close

Closing price · As of: 3. Aug 2026

Travere Therapeutics Inc (TVTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 555 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet TVTX
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	736	833	789	664	551	504	594	549	555	539	605	555
Current Assets	542	686	617	481	369	325	417	374	380	371	438	393
Cash	71	144	58	43	32	36	59	62	75	111	93	78
Cash & Short-Term Investments	491	635	567	441	325	277	371	322	320	255	323	265
Receivables	20	15	21	23	24	25	27	34	39	83	81	87
Inventory	19	21	9.4	4.5	6.0	6.4	6.2	3.9	4.1	5.5	5.9	6.4
Property, Plant & Equipment	8.6	–	–	–	–	–	–	–	–	–	–	–
Goodwill	0.9	0.8	0.8	0.8	0.8	0.7	0.8	0.8	0.8	0.8	0.8	0.8
Intangible Assets	154	106	104	100	104	103	103	103	105	109	113	109
Total Liabilities	620	553	588	589	536	535	535	516	523	465	490	456
Current Liabilities	136	139	178	173	121	190	201	182	190	135	160	125
Short-Term Debt	4.7	4.8	4.9	5.0	5.2	74	74	74	74	5.7	5.9	6.0
Accounts Payable	20	25	42	17	26	23	24	15	19	18	25	13
Long-Term Debt	376	377	377	378	378	310	310	311	311	311	312	312
Shareholders' Equity	116	280	201	74	15	-30	59	33	33	74	115	99
Retained Earnings	-1,186	-1,035	-1,126	-1,262	-1,332	-1,387	-1,447	-1,488	-1,501	-1,475	-1,473	-1,510
Shares Outstanding	76	76	76	77	78	78	83	88	89	103	90	92

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings